Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-31

Clinical Trial Update: Efficacy and Safety Study of EscharEx to Treat (Debride) Hard to Heal Wounds [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updates the efficacy and safety of EscharEx for treating hard-to-heal wounds, including venous leg ulcers and related wound types.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EscharEx (EX-03 formulation)

Snippet

Sponsor: MediWound Ltd | Conditions: Hard to Heal Wounds, Venous Leg Ulcers | Phase 2 | Status: COMPLETED